Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 529,730 |
|
|||||
| News | (1) | ||||||
| Day High | 4.09 | Low High |
|||||
| Day Low | 3.925 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ventyx Biosciences Inc | VTYX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.12 | -2.96% | 3.94 | 17:18:26 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 4.09 | 3.925 | 4.09 | 3.93 | 4.06 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,850 | 529,730 | $ 3.98 | $ 2,110,710 | - | 1.865 - 40.58 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:36:45 | 20 | $ 3.94 | USD |
Ventyx Biosciences Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 233.45M | 59.25M | - | 0 | -192.96M | -3.26 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ventyx Biosciences News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VTYX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.33 | 4.63 | 3.925 | 4.30 | 726,750 | -0.39 | -9.01% |
| 1 Month | 5.45 | 5.88 | 3.925 | 4.86 | 1,089,987 | -1.51 | -27.71% |
| 3 Months | 2.24 | 11.48 | 2.15 | 5.88 | 4,181,535 | 1.70 | 75.89% |
| 6 Months | 15.88 | 15.96 | 1.865 | 4.54 | 3,563,172 | -11.94 | -75.19% |
| 1 Year | 37.69 | 40.58 | 1.865 | 9.21 | 2,133,431 | -33.75 | -89.55% |
| 3 Years | 18.65 | 47.2508 | 1.865 | 14.45 | 1,124,802 | -14.71 | -78.87% |
| 5 Years | 18.65 | 47.2508 | 1.865 | 14.45 | 1,124,802 | -14.71 | -78.87% |
Ventyx Biosciences Description
| Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune disorders. Its lead product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors. |
